-
1
-
-
77956499693
-
Innate antimicrobial immunity in inflammatory bowel diseases
-
Beisner J, Stange EF, Wehkamp J. Innate antimicrobial immunity in inflammatory bowel diseases. Expert Rev Clin Immunol 2010; 6:809-18.
-
(2010)
Expert Rev Clin Immunol
, vol.6
, pp. 809-818
-
-
Beisner, J.1
Stange, E.F.2
Wehkamp, J.3
-
2
-
-
77954142663
-
Proinflammatory cytokines underlying the inflammation of Crohn's disease
-
Strober W, Zhang F, Kitani A, Fuss I, Fichtner-Feigl S. Proinflammatory cytokines underlying the inflammation of Crohn's disease. Curr Opin Gastroenterol 2010; 26:310-7.
-
(2010)
Curr Opin Gastroenterol
, vol.26
, pp. 310-317
-
-
Strober, W.1
Zhang, F.2
Kitani, A.3
Fuss, I.4
Fichtner-Feigl, S.5
-
3
-
-
0035487682
-
Immunological basis of inflammatory bowel disease: Role of the microcirculation
-
DOI 10.1038/sj.mn.7800095
-
Laroux FS, Grisham MB. Immunological basis of inflammatory bowel disease: role of the microcirculation. Microcirculation 2001; 8:283-301. (Pubitemid 33598134)
-
(2001)
Microcirculation
, vol.8
, Issue.5
, pp. 283-301
-
-
Laroux, F.S.1
Grisham, M.B.2
-
4
-
-
33744510694
-
Angiogenesis as a Novel Component of Inflammatory Bowel Disease Pathogenesis
-
DOI 10.1053/j.gastro.2006.03.054, PII S0016508506007396
-
Danese S, Sans M, De la Motte C, et al. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 2006; 130:2060-73. (Pubitemid 43816964)
-
(2006)
Gastroenterology
, vol.130
, Issue.7
, pp. 2060-2073
-
-
Danese, S.1
Sans, M.2
De La, M.C.3
Graziani, C.4
West, G.5
Phillips, M.H.6
Pola, R.7
Rutella, S.8
Willis, J.9
Gasbarrini, A.10
Fiocchi, C.11
-
5
-
-
58849127465
-
Evidence of endothelial dysfunction in patients with inflammatory bowel disease
-
Roifman I, Sun YC, Fedwick JP, Panaccione R, Buret AG, Liu H, Rostom A, Anderson TJ, Beck PL. Evidence of endothelial dysfunction in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2009; 7:175-82.
-
(2009)
Clin Gastroenterol Hepatol
, vol.7
, pp. 175-182
-
-
Roifman, I.1
Sun, Y.C.2
Fedwick, J.P.3
Panaccione, R.4
Buret, A.G.5
Liu, H.6
Rostom, A.7
Anderson, T.J.8
Beck, P.L.9
-
6
-
-
9344257937
-
Increased gut permeability in Crohn's disease: Is TNF the link?
-
DOI 10.1136/gut.2004.047092
-
Gibson PR. Increased gut permeability in Crohn's disease: is TNF the link? Gut 2004; 53:1724-5. (Pubitemid 39556884)
-
(2004)
Gut
, vol.53
, Issue.12
, pp. 1724-1725
-
-
Gibson, P.R.1
-
7
-
-
26844462934
-
Differential effects of NF-kappaB and p38 MAPK inhibitors and combinations thereof on TNF-alpha- and IL-1beta-induced proinflammatory status of endothelial cells in vitro
-
DOI 10.1152/ajpcell.00620.2004
-
Kuldo JM, Westra J, Asgeirsdóttir SA, Kok RJ, Oosterhuis K, Rots MG, Schouten JP, Limburg PC, Molema G. Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro. Am J Physiol Cell Physiol 2005; 289:C1229-39. (Pubitemid 41456839)
-
(2005)
American Journal of Physiology - Cell Physiology
, vol.289
, Issue.5
-
-
Kuldo, J.M.1
Westra, J.2
Asgeirsdottir, S.A.3
Kok, R.J.4
Oosterhuis, K.5
Rots, M.G.6
Schouten, J.P.7
Limburg, P.C.8
Molema, G.9
-
8
-
-
33751537126
-
TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells
-
DOI 10.1189/jlb.0905530
-
Viemann D, Goebeler M, Schmid S, Nordhues U, Klimmek K, Sorg C, Roth J. TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells. J Leukoc Biol 2006; 80:174-85. (Pubitemid 44835538)
-
(2006)
Journal of Leukocyte Biology
, vol.80
, Issue.1
, pp. 174-185
-
-
Viemann, D.1
Goebeler, M.2
Schmid, S.3
Nordhues, U.4
Klimmek, K.5
Sorg, C.6
Roth, J.7
-
9
-
-
0030331087
-
Regulation of nitric oxide synthase gene expression by cytokines
-
Yokoyama M, Hirata K, Kawashima S, Kawahara Y. Regulation of nitric oxide synthase gene expression by cytokines. J Card Fail 1996; 2(S):179-85.
-
(1996)
J Card Fail
, vol.2
, Issue.S
, pp. 179-185
-
-
Yokoyama, M.1
Hirata, K.2
Kawashima, S.3
Kawahara, Y.4
-
10
-
-
0035956947
-
Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability
-
DOI 10.1073/pnas.041359198
-
Fukumura D Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, Jain RK. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 2001; 98:2604-9. (Pubitemid 32209529)
-
(2001)
Proceedings of the National Academy of Sciences of the United States of America
, vol.98
, Issue.5
, pp. 2604-2609
-
-
Fukumura, D.1
Gohongi, T.2
Kadambi, A.3
Izumi, Y.4
Ang, J.5
Yun, C.-O.6
Buerk, D.G.7
Huang, P.L.8
Jain, R.K.9
-
11
-
-
33749318200
-
Vascular endothelial growth factor signaling to endothelial nitric oxide synthase: More than a FLeeTing moment
-
DOI 10.1161/01.RES.0000245430.24075.a4, PII 0000301220060929000002
-
Lin MI, Sessa WC. Vascular Endothelial growth factor signaling to endothelial nitric oxide synthase. Circ Res 2006; 99:666-8. (Pubitemid 44498299)
-
(2006)
Circulation Research
, vol.99
, Issue.7
, pp. 666-668
-
-
Lin, M.I.1
Sessa, W.C.2
-
12
-
-
0038449206
-
Acquired microvascular dysfunction in inflammatory bowel disease: Loss of nitric oxide-mediated vasodilation
-
DOI 10.1016/S0016-5085(03)00699-1
-
Hatoumi OA, Binion DG, Otterson MF, Gutterman DD. Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology 2003; 125:58-69. (Pubitemid 36799107)
-
(2003)
Gastroenterology
, vol.125
, Issue.1
, pp. 58-69
-
-
Hatoum, O.A.1
Binion, D.G.2
Otterson, M.F.3
Gutterman, D.D.4
-
13
-
-
20444479801
-
Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease
-
Palatka K, Serfocombining double acute accentzocombining double acute accent Z, Veréb Z, et al. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease. Scand J Gastroenterol 2005; 40:670-80.
-
(2005)
Scand J Gastroenterol
, vol.40
, pp. 670-680
-
-
Palatka, K.1
Serfozo, Z.2
Veréb, Z.3
-
14
-
-
33645880135
-
Effect of IBD sera on expression of inducible and endothelial nitric oxide synthase in human umbilical vein endothelial cells
-
Palatka K, Serfocombining double acute accentzocombining double acute accent Z, Veréb Z, et al. Effect of IBD sera on expression of inducible and endothelial nitric oxide synthase in human umbilical vein endothelial cells. World J Gastroenterol 2006; 12:1730-8.
-
(2006)
World J Gastroenterol
, vol.12
, pp. 1730-1738
-
-
Palatka, K.1
Serfozo, Z.2
Veréb, Z.3
-
15
-
-
0035072493
-
VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: A novel mechanism of chronic intestinal inflammation
-
DOI 10.1016/S0002-9270(00)02320-0, PII S0002927000023200
-
Kanazawa S, Tsunoda T, Onuma E, Majima T, Kagiyama M, Kikuchi K. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 2001; 3:822-8. (Pubitemid 32240738)
-
(2001)
American Journal of Gastroenterology
, vol.96
, Issue.3
, pp. 822-828
-
-
Kanazawa, S.1
Tsunoda, T.2
Onuma, E.3
Majima, T.4
Kagiyama, M.5
Kikuchi, K.6
-
16
-
-
0032750425
-
Nitric-oxide an endothelial survival factor
-
Dimmeler S, Zeiher AM. Nitric-oxide an endothelial survival factor. Cell Death Differ 1999; 6:964-8.
-
(1999)
Cell Death Differ
, vol.6
, pp. 964-968
-
-
Dimmeler, S.1
Zeiher, A.M.2
-
17
-
-
0033125226
-
Antitumor necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results, and safety
-
Sandborn WJ, Hanauer SB. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm Bowel Dis 1999; 5:119-33.
-
(1999)
Inflamm Bowel Dis
, vol.5
, pp. 119-133
-
-
Sandborn, W.J.1
Hanauer, S.B.2
-
18
-
-
70449347809
-
Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe - A Hungarian nationwide observational study
-
Miheller P, Lakatos PL, Horváth G, et al. Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe - a Hungarian nationwide observational study. BMC Gastroenterol 2009; 9:66.
-
(2009)
BMC Gastroenterol
, vol.9
, pp. 66
-
-
Miheller, P.1
Lakatos, P.L.2
Horváth, G.3
-
19
-
-
32044474228
-
TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: A novel anti-inflammatory mechanism of infliximab in Crohn's disease
-
Danese S, Sans M, Scaldaferri F, Fiocchi C, et al. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease. J Immunol 2006; 176:2617-24. (Pubitemid 43201714)
-
(2006)
Journal of Immunology
, vol.176
, Issue.4
, pp. 2617-2624
-
-
Danese, S.1
Sans, M.2
Scaldaferri, F.3
Sgambato, A.4
Rutella, S.5
Cittadini, A.6
Pique, J.M.7
Panes, J.8
Katz, J.A.9
Gasbarrini, A.10
Fiocchi, C.11
-
20
-
-
37549028415
-
Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease
-
Schinzari FAA, Armuzzi A, De Pascalis B, Mores N, Tesauro M, Melina D, Cardillo C. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease. Clin Pharmacol Ther 2008; 83:70-6.
-
(2008)
Clin Pharmacol Ther
, vol.83
, pp. 70-76
-
-
Schinzari, F.A.A.1
Armuzzi, A.2
De Pascalis, B.3
Mores, N.4
Tesauro, M.5
Melina, D.6
Cardillo, C.7
-
21
-
-
0029080027
-
Isolation and longterm culture of human intestinal microvascular endothelial cells
-
Haraldsen G, Rugtveit J, Kvale D, Scholz T, Muller WA, Hovig T, Brandtzaeg P. Isolation and longterm culture of human intestinal microvascular endothelial cells. Gut 1995; 37:225-34.
-
(1995)
Gut
, vol.37
, pp. 225-234
-
-
Haraldsen, G.1
Rugtveit, J.2
Kvale, D.3
Scholz, T.4
Muller, W.A.5
Hovig, T.6
Brandtzaeg, P.7
-
22
-
-
0038446795
-
Gene and protein expression profiling of human cerebral endothelial cells activated with tumor necrosis factor-alpha
-
DOI 10.1016/S0169-328X(03)00185-2
-
Franzen B, Duvefelt K, Jonsson C, Engelhardt B, Ottervald J, Wickman M, Yang Y, Schuppe-Koistinen I. Gene and protein expression profiling of human cerebral endothelial cells activated with tumor necrosis factor-alpha. Brain Res Mol Brain Res 2003; 115:130-46. (Pubitemid 36859863)
-
(2003)
Molecular Brain Research
, vol.115
, Issue.2
, pp. 130-146
-
-
Franzen, B.1
Duvefelt, K.2
Jonsson, C.3
Engelhardt, B.4
Ottervald, J.5
Wickman, M.6
Yang, Y.7
Schuppe-Koistinen, I.8
-
23
-
-
20444464523
-
Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease
-
DOI 10.1136/jcp.2004.021840
-
Sanders DSA. Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease. J Clin Pathol 2005; 58:568-72. (Pubitemid 40814012)
-
(2005)
Journal of Clinical Pathology
, vol.58
, Issue.6
, pp. 568-572
-
-
Sanders, D.S.A.1
-
24
-
-
0042889191
-
Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis
-
Kimura H, Esumi H. Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis Acta Bioch Pol 2003; 50:49-59.
-
(2003)
Acta Bioch Pol
, vol.50
, pp. 49-59
-
-
Kimura, H.1
Esumi, H.2
-
25
-
-
77951699944
-
Long-term anti-TNF-alpha treatments reverse the endothelial dysfunction in rheumatoid arthritis: The biological coherence between synovial and endothelial inflammation
-
Capria A, De Nardo D, Baffetti FR, Barbini U, Violo A, Tondo T, Fontana L. Long-term anti-TNF-alpha treatments reverse the endothelial dysfunction in rheumatoid arthritis: the biological coherence between synovial and endothelial inflammation. Int J Immunopathol Pharmacol 2010; 23:255-62.
-
(2010)
Int J Immunopathol Pharmacol
, vol.23
, pp. 255-262
-
-
Capria, A.1
De Nardo, D.2
Baffetti, F.R.3
Barbini, U.4
Violo, A.5
Tondo, T.6
Fontana, L.7
-
26
-
-
79953797881
-
Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease
-
Rutella S, Fiorino G, Vetrano S, et al. Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease. Am J Gastroenterol 2011; 106:762-70.
-
(2011)
Am J Gastroenterol
, vol.106
, pp. 762-770
-
-
Rutella, S.1
Fiorino, G.2
Vetrano, S.3
-
27
-
-
0036734321
-
High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease
-
Martínez-Borra J, López-Larrea C, González S, et al. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease. Am J Gastroenterol 2002; 97:2350-6.
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 2350-2356
-
-
Martínez-Borra, J.1
López-Larrea, C.2
González, S.3
-
28
-
-
53249149631
-
Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1
-
Yan G, You B, Chen SP, Liao JK, Sun J. Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1. Circ Res 2008; 103:591-7.
-
(2008)
Circ Res
, vol.103
, pp. 591-597
-
-
Yan, G.1
You, B.2
Chen, S.P.3
Liao, J.K.4
Sun, J.5
-
29
-
-
0033539585
-
Serum from patients with severe heart failure downregulates eNOS and is proapoptotic. Role of tumor necrosis factor-alpha
-
Agnoletti L, Curello S, Bachetti T, et al. Serum from patient with severe heart failure downregulates eNOS and is proapoptotic. Role of tumor necrosis factor-alpha. Circulation 1999; 100:1983-91. (Pubitemid 29529291)
-
(1999)
Circulation
, vol.100
, Issue.19
, pp. 1983-1991
-
-
Agnoletti, L.1
Curello, S.2
Bachetti, T.3
Malacarne, F.4
Gaia, G.5
Comini, L.6
Volterrani, M.7
Bonetti, P.8
Parrinello, G.9
Cadei, M.10
Grigolato, P.G.11
Ferrari, R.12
-
30
-
-
0032555509
-
Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells
-
DOI 10.1074/jbc.273.34.22128
-
Giraudo E, Primo L, Audero E, Gerber HP, Koolwijk P, Soker S, Klagsbrun M, Ferrara N, Bussolino F. Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. J Biol Chem 1998; 273:22128-35. (Pubitemid 28405397)
-
(1998)
Journal of Biological Chemistry
, vol.273
, Issue.34
, pp. 22128-22135
-
-
Giraudo, E.1
Primo, L.2
Audero, E.3
Gerber, H.-P.4
Koolwijk, P.5
Soker, S.6
Klagsbrun, M.7
Ferrara, N.8
Bussolino, F.9
|